TickerFacts.

A business in context

STOK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-02 · 0001966716-26-000014

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001780088-26-000023

  3. 4 · Ownership change

    Report date 2026-09-23 · 0001685994-26-000009

  4. 8-K · Current report

    Report date 2026-09-22 · 0001193125-26-402820 · Items 5.02

  5. 4 · Ownership change

    Report date 2026-09-01 · 0001780088-26-000021

  6. 4 · Ownership change

    Report date 2026-08-14 · 0001966716-26-000012

  7. 4 · Ownership change

    Report date 2026-08-14 · 0001780088-26-000019

  8. 4 · Ownership change

    Report date 2026-08-14 · 0001522780-26-000007

  9. 4 · Ownership change

    Report date 2026-08-03 · 0001780088-26-000017

  10. 8-K · Current report

    Report date 2026-08-03 · 0001193125-26-330804 · Items 8.01,9.01

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-330557

  12. 8-K · Current report

    Report date 2026-08-03 · 0001193125-26-330537 · Items 2.02,9.01

  13. 8-K · Current report

    Report date 2026-06-30 · 0001193125-26-289409 · Items 7.01,8.01,9.01

  14. 8-K · Current report

    Report date 2026-06-03 · 0001193125-26-257394 · Items 5.07

  15. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-212020 · Items 2.02,9.01

  16. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211874

  17. DEF 14A · Proxy statement

    Report date 2026-06-03 · 0001193125-26-170362

  18. 8-K · Current report

    Report date 2026-04-03 · 0001193125-26-145524 · Items 5.02,7.01,9.01

  19. 8-K · Current report

    Report date 2026-03-23 · 0001193125-26-129168 · Items 4.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-108362

  21. 8-K · Current report

    Report date 2026-02-13 · 0001193125-26-088205 · Items 5.02

  22. 8-K · Current report

    Report date 2026-01-21 · 0001193125-26-022569 · Items 1.01,2.03

  23. 8-K · Current report

    Report date 2026-01-11 · 0001193125-26-009781 · Items 2.02,7.01,8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-05 · 0001193125-25-308781 · Items 7.01,8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-264720

  26. 8-K · Current report

    Report date 2025-11-04 · 0001193125-25-264644 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-10-05 · 0001193125-25-230925 · Items 5.02,9.01

  28. 8-K/A · Current report

    Report date 2025-06-03 · 0001193125-25-207401 · Items 5.07

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-107332

  30. 8-K · Current report

    Report date 2025-08-12 · 0000950170-25-107275 · Items 2.02,7.01,9.01

  31. 8-K · Current report

    Report date 2025-08-11 · 0001193125-25-177433 · Items 7.01,9.01

  32. 8-K · Current report

    Report date 2025-07-10 · 0001193125-25-157364 · Items 7.01,9.01

  33. 8-K · Current report

    Report date 2025-06-03 · 0001193125-25-134882 · Items 5.07

  34. 8-K · Current report

    Report date 2025-06-04 · 0001193125-25-134447 · Items 7.01,8.01,9.01

  35. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-070296

  36. 8-K · Current report

    Report date 2025-05-13 · 0000950170-25-069783 · Items 2.02,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-06-03 · 0001193125-25-089188

  38. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-041170

  39. 8-K · Current report

    Report date 2025-03-18 · 0000950170-25-040758 · Items 2.02,5.02,7.01,9.01

  40. 8-K · Current report

    Report date 2025-02-14 · 0001193125-25-028650 · Items 1.01,7.01,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 12 transaction rows12SGrant / award: 2 transaction rows2AExercise / conversion: 6 transaction rows6MTax / exercise payment: 0 transaction rows0FGift: 16 transaction rows16G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

36 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-23
2026-09-25
Cumbo AlexanderA · Grant / award
Acquired
Director Stock Option (Right to Buy)
Derivative security
39674.00.0
2026-09-01
2026-09-03
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1600.031.06
2026-09-01
2026-09-03
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock3945.030.51
2026-08-18
2026-08-18
Allan JonathanS · Sale
Disposed
Common Stock145.032.47
2026-08-18
2026-08-18
Allan JonathanS · Sale
Disposed
Common Stock2716.032.01
2026-08-18
2026-08-18
Ticho BarryS · Sale
Disposed
Common Stock242.032.47
2026-08-18
2026-08-18
Ticho BarryS · Sale
Disposed
Common Stock4525.032.01
2026-08-18
2026-08-18
Kaye Edward M. MDS · Sale
Disposed
Common Stock637.032.47
2026-08-18
2026-08-18
Kaye Edward M. MDS · Sale
Disposed
Common Stock11930.032.01
2026-08-14
2026-08-18
Allan JonathanM · Exercise / conversion
Acquired
Common Stock6000.00.0
2026-08-14
2026-08-18
Allan JonathanM · Exercise / conversion
Disposed
Performance Stock Units
Derivative security
6000.00.0
2026-08-14
2026-08-18
Ticho BarryM · Exercise / conversion
Acquired
Common Stock10000.00.0
2026-08-14
2026-08-18
Ticho BarryM · Exercise / conversion
Disposed
Performance Stock Units
Derivative security
10000.00.0
2026-08-14
2026-08-18
Kaye Edward M. MDM · Exercise / conversion
Acquired
Common Stock26250.00.0
2026-08-14
2026-08-18
Kaye Edward M. MDM · Exercise / conversion
Disposed
Performance Stock Units
Derivative security
26250.00.0
2026-08-03
2026-08-05
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock5907.028.95
2026-08-03
2026-08-05
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock1269.029.45
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
17786.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
29747.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
29555.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
29555.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
14777.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
14777.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
11650.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
11650.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
21000.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
21000.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
19441.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
19441.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
7639.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
7639.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Disposed
Stock Option (Right to Buy)
Derivative security
29747.00.0
2026-07-16
2026-07-17
Harrison Seth LoringG · Gift
Acquired
Stock Option (Right to Buy)
Derivative security
17786.00.0
2026-07-15
2026-07-17
McCauley ThomasA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
225000.00.0
2026-07-01
2026-07-06
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock500.033.27
2026-07-01
2026-07-06
Ticho Barry
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock6728.032.62

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001623526Stoke Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • ASOthera Pharmaceuticals, Inc. · former SEC name · 2014-11-24 to 2014-11-24

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$36.55M$39.26M
2023-12-31$8.78M$9.71M
2022-12-31$12.40M$14.28M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗